590782388	590782388	CD	B-NP	O
|	|	NN	I-NP	O
VMC	VMC	NN	I-NP	O
|	|	NN	I-NP	O
87702030	87702030	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7331709	7331709	CD	B-NP	O
|	|	CC	I-NP	O
4/7/2006	4/7/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
URINARY	URINARY	NN	I-NP	I-protein
TRACT	TRACT	NN	I-NP	I-protein
INFECTION	INFECTION	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/17/2006	6/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/17/2006	4/17/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SIMMON	SIMMON	NNP	B-NP	O
,	,	,	O	O
JEFFERY	JEFFERY	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
:	:	:	O	O
Addendum	Addendum	NN	B-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
record	record	NN	B-NP	O
number	number	NN	I-NP	O
#	#	#	B-NP	O
8830141	8830141	CD	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
dictated	dictate	VBN	I-VP	O
by	by	IN	B-PP	O
Kovats	Kovats	NNP	B-NP	O
,	,	,	O	O
Doyle	Doyle	NNP	B-NP	O
Bradly	Bradly	NNP	I-NP	O
.	.	.	O	O

ADDENDUM	ADDENDUM	NN	B-NP	O
TO	TO	TO	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
SUMMARY	SUMMARY	NN	I-NP	O
:	:	:	O	O
NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Neurology	Neurology	NN	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
somnolence	somnolence	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
son	son	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
thinks	think	VBZ	B-VP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
consult	consult	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
get	get	VBP	B-VP	O
an	an	DT	B-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
with	with	IN	B-PP	O
gadolinium	gadolinium	NN	B-NP	O
contrast	contrast	NN	I-NP	O
to	to	TO	B-VP	O
look	look	VB	I-VP	O
for	for	IN	B-PP	O
leptomeningeal	leptomeningeal	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
sources	source	NNS	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
somnolence	somnolence	NN	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
treatable	treatable	JJ	B-ADJP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
an	an	DT	B-NP	O
EEG	EEG	NN	I-NP	B-protein
be	be	VB	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
EEG	EEG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
right	right	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
infarct	infarct	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
known	know	VBN	I-VP	O
and	and	CC	O	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
interval	interval	JJ	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Gadolinium	Gadolinium	NN	B-NP	O
contrast	contrast	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
given	give	VBN	I-VP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
too	too	RB	B-ADJP	O
agitated	agitate	VBN	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
moving	move	VBG	I-VP	O
too	too	RB	B-ADVP	O
much	much	RB	I-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
check	check	VBP	B-VP	O
certain	certain	JJ	B-NP	O
labs	lab	NNS	I-NP	O
including	include	VBG	B-PP	O
folate	folate	NN	B-NP	O
,	,	,	I-NP	O
B12	B12	NN	I-NP	B-protein
,	,	,	I-NP	O
TSH	TSH	NN	I-NP	O
and	and	CC	I-NP	O
RPR	RPR	NN	I-NP	B-protein
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
essentially	essentially	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
but	but	CC	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Synthroid	Synthroid	NNP	B-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
agreed	agree	VBD	B-VP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
somnolence	somnolence	NN	I-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
somnolence	somnolence	NN	I-NP	O
continues	continue	VBZ	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
near	near	JJ	I-NP	O
future	future	JJ	I-NP	O
further	further	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Leptomeningeal	Leptomeningeal	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
spread	spread	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
known	known	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
interval	interval	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
oncological	oncological	JJ	I-NP	O
process	process	NN	I-NP	O
the	the	DT	B-NP	O
likeliness	likeliness	NN	I-NP	O
of	of	IN	B-PP	O
leptomeningeal	leptomeningeal	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
1000	1000	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Niferex-150	Niferex-150	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lamictal	Lamictal	JJ	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Seroquel	Seroquel	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lidoderm	Lidoderm	NNP	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
patch	patch	NN	I-NP	O
topically	topically	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Cymbalta	Cymbalta	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
96.7	96.7	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
hypertensive	hypertensive	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
103	103	CD	B-NP	O
to	to	TO	I-NP	O
152	152	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
54	54	CD	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
diastolic	diastolic	JJ	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
urinating	urinate	VBG	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
one-to-one	one-to-one	NN	I-NP	O
sitter	sitter	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
fully	fully	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
the	the	DT	B-NP	O
extended	extend	VBN	I-NP	O
release	release	NN	I-NP	O
formulation	formulation	NN	I-NP	O
for	for	IN	B-PP	O
improved	improved	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
and	and	CC	I-NP	O
convenience	convenience	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Klein	Klein	NNP	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
my	my	PRP$	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	B-NP	O
Baney	Baney	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
010-743-1248	010-743-1248	CD	B-NP	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Duplaga	Duplaga	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
891-850-7392	891-850-7392	CD	B-NP	O
and	and	CC	O	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
11/18/06	11/18/06	CD	B-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
scheduled	schedule	VBN	I-VP	O
on	on	IN	B-PP	O
8/21/06	8/21/06	CD	B-NP	O
at	at	IN	B-PP	O
08	08	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
'S	'S	NNP	I-NP	O
ONCOLOGIST	ONCOLOGIST	NNP	I-NP	O
:	:	:	O	O
Rusty	Rusty	NNP	B-NP	O
Magnall	Magnall	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
at	at	IN	B-PP	O
Purcmount	Purcmount	NNP	B-NP	O
Catstic	Catstic	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Cancer	Cancer	NNP	I-NP	O
Institute	Institute	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
763-624-6925	763-624-6925	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
e-mail	e-mail	JJ	I-NP	O
address	address	NN	I-NP	O
is	be	VBZ	B-VP	O
Gdupxqa	Gdupxqa	NNP	B-NP	O
Xlmfl	Xlmfl	NNP	I-NP	O
@	@	NNP	I-NP	O
RPRR	RPRR	NNP	I-NP	O
.	.	.	O	O

Ttdtfdm.uqw	Ttdtfdm.uqw	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-8248157	3-8248157	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Darryl	Darryl	NNP	B-NP	O
Mak	Mak	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Man	Man	NNP	I-NP	O
Ponce	Ponce	NNP	I-NP	O
Ale	Ale	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Weldon	Weldon	NNP	B-NP	O
Polakoff	Polakoff	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Port	Port	NNP	I-NP	O
,	,	,	O	O
Well	Well	NNP	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GRILLETTE	GRILLETTE	NNP	B-NP	O
,	,	,	O	O
STEPHAN	STEPHAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MAD	MAD	NNP	B-NP	O
,	,	,	O	O
ELIJAH	ELIJAH	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2896395	2896395	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/10/06	3/10/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/10/06	3/10/06	CD	B-NP	O

